This job is closed
We regret to inform you that the job you were interested in has been closed. Although this specific position is no longer available, we encourage you to continue exploring other opportunities on our job board.
Mitsubishi Tanabe Pharma - Jersey City, NJ
posted 7 days ago
Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, which has a storied reputation of over 300 years. MTPA is rapidly expanding its operations across all functional areas, with a commitment to patients and their communities through a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases. The Director, Medical Science MSES, will be primarily responsible for creating plans for early clinical development and implementing Early Development plans aligned with the company's disease and pathway strategies. This role involves leading clinical and scientific aspects of Early Development studies from Phase 0 through Proof-of-Concept studies, contributing to accelerating the company's pipeline from portfolio entry to Proof-of-Concept (PoC). The Director, MSES, should have expertise in early-stage clinical development, biomarker development, precision medicine, and disease biology research.
Match and compare your resume to any job description
Start Matching